Zyla Life Sciences Deferred Tax Liabilities, Financing Arrangements
Zyla Life Sciences had Deferred Tax Liabilities, Financing Arrangements of $1.45 million as of 2017-12-31, per its 10-K filed 2019-03-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesFinancingArrangements · last filed 2019-03-29
- 2017-12-31: Deferred Tax Liabilities, Financing Arrangements $1.45M.
- 2016-12-31: Deferred Tax Liabilities, Financing Arrangements $5.04M.
- 2015-12-31: Deferred Tax Liabilities, Financing Arrangements $6.32M.
| Period end | Deferred Tax Liabilities, Financing Arrangements |
|---|---|
| 2017-12-31 | $1.45M 10-K · filed 2019-03-29 |
| 2016-12-31 | $5.04M 10-K · filed 2018-03-16 |
| 2015-12-31 | $6.32M 10-K · filed 2016-03-11 |